Exercise Induced QT Interval Changes in Response to Intermittent and Continuous Graded Exercise Tests
NCT ID: NCT04005027
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
50 participants
INTERVENTIONAL
2019-07-08
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Training Intensity on Microvascular Function
NCT07237854
Value of Ankle Pressure Index After Maximal Exercise Tests
NCT01812343
Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population
NCT04653857
Inter- and Intra-individual Variation in Acute Responses to Two Different Warm-up Types.
NCT04738617
Enhancing Prevention of Injuries in Community Youth and Adult Amateur Football Players
NCT06748443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators aim to recruit approximately 50 players from Sunderland Foundation of Light regional training centre (RTC) with a minimum sample size of 24. We will use a replicated randomised repeated measures crossover design in which the participants will be randomised to different sequences of four experimental conditions; two continuous graded exercise tests, and two intermittent graded exercise tests, randomised using a Latin square counterbalanced design. Participants will be required to perform all four exercise conditions at approximately the same time of day (± 1 h) to control for within-athlete variation. Each exercise condition will be separated by at least 72 h with all testing sessions complete within a 2-4 week period. The following constraints will be placed on the participants to improve the strength of the study design:
* Avoid strenuous physical activity for 48-72 h prior to testing.
* Avoid caffeine consumption for 4 h prior to testing and alcohol at least 12 h.
* Maintain normal hydration by drinking to thirst prior to testing.
* Consume a high carbohydrate meal 2 h prior to testing.
Exercise testing
Exercise will be performed in a temperature controlled physiology laboratory. Participants will perform two graded exercise tests, repeated twice. The continuous graded exercise test (CONT) will increase treadmill speed incrementally using three minute stage duration on a motorised treadmill. The initial speed will be individualised designed to evoke a heart rate around 40-50% of one's age predicted maximal heart rate using 206.9 - (0.67\* age \[yrs\]). This will be gauged from a 3 minute low intensity warm-up at the start. The speed will increase by 1 km.hr-1 every three minutes until volitional exhaustion. The gradient of the treadmill will be set at 1 % to reflect energy expenditure of over-ground running. Gradient will only be increased if the performer reaches the limits of their stride frequency and length and therefore it would be inappropriate to continue to increase speed of the belt. The intermittent graded exercise test (INT) will follow the same procedure. However, the speed within each three minute exercise bout will vary every 30 s between the target speed, and a complete pause for 30 s. The acceleration of the treadmill belt will be set to its maximum capability. Participants will be familiarised with this acceleration to ensure safety.
Blood lactate
A post- exercise capillary blood lactate sample will be taken from the participants' finger- tip of their non-dominant hand. The finger -tip will be punctured using a disposable lancet to obtain the capillary blood sample. The small sample of blood is then collected and analysed using a portable blood lactate analyser (Lactate Pro). The finger will be cleaned using an alcohol swab to reduce infection. The researcher taking the blood will be wearing appropriate personal protective equipment including latex-free gloves when obtaining the blood. The blood measure is used as an end-point (among others) to confirm if maximal effort has been performed.
Gas analysis Respiratory data will be recorded continuously throughout each exercise test using an online breath by breath metabolic gas cart (Cortex, metamax). Certified standard calibration gases of 16.4% O2 and 4.5% CO2 will be used (Cryoservice Ltd, Worcester, UK). The turbine flow meter, used for the determination of V ̇E, will be calibrated with a 3 L syringe (Cosmed Srl). Room temperature (°C), relative humidity (%) and barometric pressure (mmHg) will recorded separately from a weather station. Rating of Perceived Exertion (RPE) (modified category-ratio scale) (Foster et al., 2001) expressed as an arbitrary unit (AU) will obtained in the final 15 s of each speed stage.
All breath-by-breath data will be processed using 30 s retrograde averages (Midgley et al., 2007) obtained directly from the metamax software®, with the highest VO2 in the final stages deemed to be VO2max (Midgley et al., 2007). The use of middle 5 of 7 breath averaging will be used for assessment of submaximal data including the ventilatory threshold (Nichols et al 2015). VO2max will be deemed to be achieved if ≥2 of the following criteria are met (Keren et al., 1980): a plateau in VO2 defined as a change of less than 0.2 L.min-1 despite an increasing workload (Howley et al., 1995), a respiratory exchange ratio (RER) of \>1.15, a maximal heart rate (HRpeak) within ±10 beats.min-1 of the estimated HRpeak (206.9 - \[0.67 x age\]), an RPE greater than 8 (Howley et al., 1995) and a 5 min post blood lactate of \> 8 mM.
Echocardiography, Electrocardiography and QT interval analysis
A standard transthoracic echocardiogram (TTE) will be used to investigate the existence of any structural cardiac abnormalities. An initial assessment will be performed on the first visit to the laboratory lasting a minimum of 40-45 min. The screening will be carried out by a qualified cardiac physiologist. A 5 minute resting, recovery and exercise 12 lead ECG will be performed using the Mason- Likar set- up. The ECG will be recorded at a paper speed of 25 mm/s. The QT interval will be determined as the interval between the beginning of the Q or R wave to the peak of the T wave, and the point where a tangent drawn along the maximum slope of the descending limb of the T wave crosses the isoelectric TP baseline. The corrected QT interval (QTc) will be calculated using an automated algorithm averaging across 3 beats for each three minute stage, and 60 second recovery phases. We will use a number of different formulas to assess the corrected QT (QTc);
Bazett's (QTc =QT/!RR), Fridericia (QTc=QT/\[RR/1000\]1/3), Framingham (QTc=QT+\[0.154 \* {1000-RR}\]) Hodges (QTc=QT+1.75 \* \[{60 000/RR}260\])
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intermittent graded exercise (INT)
The intermittent graded exercise test (INT) increase treadmill speed incrementally using three minute stage duration on a motorised treadmill. However, the speed within each three minute exercise bout will vary every 30 s between the target speed, and a complete pause for 30 s. The acceleration of the treadmill belt will be set to its maximum capability.
Intermittent graded exercise test
Participants will run on a treadmill until volitional exhaustion. The speed of the treadmill belt will increase incrementally every 3 minutes. Within each 3 minute stage the speed will vary between the target speed and a complete pause (e.g target speed = 8 km/hr)
Continuous graded exercise (CONT)
The continuous graded exercise test (CONT) will increase treadmill speed incrementally using three minute stage duration on a motorised treadmill
Intermittent graded exercise test
Participants will run on a treadmill until volitional exhaustion. The speed of the treadmill belt will increase incrementally every 3 minutes. Within each 3 minute stage the speed will vary between the target speed and a complete pause (e.g target speed = 8 km/hr)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent graded exercise test
Participants will run on a treadmill until volitional exhaustion. The speed of the treadmill belt will increase incrementally every 3 minutes. Within each 3 minute stage the speed will vary between the target speed and a complete pause (e.g target speed = 8 km/hr)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be participating in \~3 - 6 h of soccer training per week as part of a soccer academy or regional training centre (RTC)
Exclusion Criteria
* At least one cardiovascular, respiratory or metabolic disease.
* Have suffered from a lower limb musculoskeletal injury in the past 6 months
16 Years
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheffield Hallam University
OTHER
Newcastle University
OTHER
Teesside University
OTHER
University of Sunderland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Will Evans
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunderland University
Sunderland, Tyne and Wear, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LQT004291
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.